Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Margot Thiaucourt"'
Autor:
Maximilian Kittel, Preetha Moorthy, Sonika Rao, Marie Halfmann, Margot Thiaucourt, Maximilian Strauß, Verena Haselmann, Nandhini Santhanam, Fabian Siegel, Michael Neumaier
Publikováno v:
Digital Health, Vol 9 (2023)
Background A major challenge in healthcare is the interpretation of the constantly increasing amount of clinical data of interest to inpatients for diagnosis and therapy. It is vital to accurately structure and represent data from different sources t
Externí odkaz:
https://doaj.org/article/b5c55babb9614296add4eba053f504e3
Autor:
Catharina Gerhards, Margot Thiaucourt, Maximilian Kittel, Celine Becker, Volker Ast, Michael Hetjens, Michael Neumaier, Verena Haselmann
Publikováno v:
International Journal of Infectious Diseases, Vol 107, Iss , Pp 221-227 (2021)
Introduction: The longevity of antibody levels against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the duration of immunity are current topics of major scientific interest. Antibody kinetics during the acute phase are well studie
Externí odkaz:
https://doaj.org/article/a059737a9257407c8acf889fa7407a94
Autor:
Maximilian Kittel, Peter Findeisen, Maria-Christina Muth, Margot Thiaucourt, Catharina Gerhards, Michael Neumaier, Verena Haselmann
Publikováno v:
International Journal of Infectious Diseases, Vol 105, Iss , Pp 632-638 (2021)
Background: The detection of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is mandatory for the diagnosis, retrospective assessment of disease progression, and correct evaluation of the current infection situation in the
Externí odkaz:
https://doaj.org/article/66b35e8e9c074c17aaf1ea5e1117e4cf
Autor:
Maximilian Kittel, Maria Christina Muth, Ingrid Zahn, Heinz-Jürgen Roth, Margot Thiaucourt, Catharina Gerhards, Verena Haselmann, Michael Neumaier, Peter Findeisen
Publikováno v:
International Journal of Infectious Diseases, Vol 103, Iss , Pp 590-596 (2021)
Objective: Numerous immunoassays for detecting antibodies directed against SARS-CoV-2 have been rapidly developed and released. Validations of these have been performed with a limited number of samples. The lack of standardisation might lead to signi
Externí odkaz:
https://doaj.org/article/f275ef8c491247499e74b9f0974ad636
Autor:
Catharina Gerhards, Margot Thiaucourt, Michael Hetjens, Verena Haselmann, Michael Neumaier, Maximilian Kittel
Publikováno v:
Vaccines, Vol 11, Iss 3, p 701 (2023)
Background: Longitudinal humoral SARS-CoV-2 (severe acute respiratory syndrome coronavirus type 2) immunity for up to 15 months due to vaccination, the efficacy of vaccination strategies (homologous, vector–vector versus heterologous, vector–mRNA
Externí odkaz:
https://doaj.org/article/82f34af21b6d42698a9126b7f4c40b95
Autor:
Catharina Gerhards, Maximilian Kittel, Volker Ast, Peter Bugert, Matthias F. Froelich, Michael Hetjens, Verena Haselmann, Michael Neumaier, Margot Thiaucourt
Publikováno v:
Viruses, Vol 15, Iss 2, p 454 (2023)
Background: The duration of anti-SARS-CoV-2-antibody detectability up to 12 months was examined in individuals after either single convalescence or convalescence and vaccination. Moreover, variables that might influence an anti-RBD/S1 antibody declin
Externí odkaz:
https://doaj.org/article/28463021d53a4d7ebb41ec2ccb491dde
Autor:
Frederic Jungbauer, Catharina Gerhards, Margot Thiaucourt, Michael Behnes, Nicole Rotter, Angela Schell, Verena Haselmann, Michael Neumaier, Maximilian Kittel
Publikováno v:
Life, Vol 12, Iss 7, p 968 (2022)
Sudden onset of anosmia is a phenomenon often associated with developing COVID-19 disease and has even been described as an initial isolated symptom in individual cases. In this case-control study, we investigated the feasibility of this condition as
Externí odkaz:
https://doaj.org/article/0faca02bed454daaac20777fbdb492a4
Autor:
Volker Ast, Maximilian Kittel, Margot Thiaucourt, Verena Haselmann, Catharina Gerhards, Michael Neumaier, Michael Hetjens, Celine Becker
Publikováno v:
International Journal of Infectious Diseases, Vol 107, Iss, Pp 221-227 (2021)
International Journal of Infectious Diseases
International Journal of Infectious Diseases
INTRODUCTION: The longevity of antibody levels against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the duration of immunity are current topics of major scientific interest. Antibody kinetics during the acute phase are well studie
Autor:
Michael Neumaier, Verena Haselmann, Peter Findeisen, Margot Thiaucourt, Catharina Gerhards, Maximilian Kittel, Maria-Christina Muth
Publikováno v:
International Journal of Infectious Diseases
International Journal of Infectious Diseases, Vol 105, Iss, Pp 632-638 (2021)
International Journal of Infectious Diseases, Vol 105, Iss, Pp 632-638 (2021)
Background The detection of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is mandatory for the diagnosis, retrospective assessment of disease progression, and correct evaluation of the current infection situation in the p
Autor:
Michael Neumaier, I. Zahn, Catharina Gerhards, Maximilian Kittel, Margot Thiaucourt, Maria Christina Muth, Heinz Jürgen Roth, Peter Findeisen, Verena Haselmann
Publikováno v:
International Journal of Infectious Diseases, Vol 103, Iss, Pp 590-596 (2021)
International Journal of Infectious Diseases
International Journal of Infectious Diseases
Highlights • FDA-EUA approved anti-SARS-CoV-2 tests compare favorably with others. • longitudinal patterns of antibody development are subject to high individual variability. • comparing the assays of leading manufacturers, there are considerab